Roche Gets Second Chance In Accutane Liability Suit; Pre-emption Still Possible

A New Jersey appeals court vacated a $2.6 million jury verdict against Roche and ordered a new trial to determine if its acne drug Accutane (isotretinoin) caused a plaintiff's inflammatory bowel disease